Log In
Print
BCIQ
Print
Print this Print this
 

MetMAb, onartuzumab (RG3638)

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionMonovalent mAb against c-Met proto-oncogene (MET; HGFR)
Molecular Target c-Met proto-oncogene (MET) (HGFR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today